SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-006019
Filing Date
2024-01-24
Accepted
2024-01-24 06:02:07
Documents
22
Period of Report
2024-01-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm243921d1_8k.htm   iXBRL 8-K 56424
2 EXHIBIT 4.1 tm243921d1_ex4-1.htm EX-4.1 117919
3 EXHIBIT 4.2 tm243921d1_ex4-2.htm EX-4.2 117381
4 EXHIBIT 10.1 tm243921d1_ex10-1.htm EX-10.1 285853
5 EXHIBIT 10.2 tm243921d1_ex10-2.htm EX-10.2 56231
6 EXHIBIT 10.3 tm243921d1_ex10-3.htm EX-10.3 146881
7 EXHIBIT 10.4 tm243921d1_ex10-4.htm EX-10.4 271880
8 EXHIBIT 10.5 tm243921d1_ex10-5.htm EX-10.5 142809
9 EXHIBIT 10.6 tm243921d1_ex10-6.htm EX-10.6 26489
10 EXHIBIT 99.1 tm243921d1_ex99-1.htm EX-99.1 26015
14 GRAPHIC image_001.jpg GRAPHIC 4132
  Complete submission text file 0001104659-24-006019.txt   1710909

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA otlk-20240122.xsd EX-101.SCH 3572
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE otlk-20240122_lab.xml EX-101.LAB 34750
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE otlk-20240122_pre.xml EX-101.PRE 22381
16 EXTRACTED XBRL INSTANCE DOCUMENT tm243921d1_8k_htm.xml XML 3393
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37759 | Film No.: 24554142
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)